Table 6.
Natural products used for preclinical research.
| Name | Intervention approach | Drug dosage | Duration (weeks) | Summary of main findings (compared with IDD group) | References |
|---|---|---|---|---|---|
| Resveratrol | Intragastric administration | 50 mg/kg/d | 4 | Decrease Pfirrmann MRI grade; Alcian blue: increase the content of ECM; SA-β-Gal staining: the number of positive cells decreases | [18] |
| Curcumin | Injected intraperitoneally | 100 mg/kg/d | 4 | Decrease Pfirrmann MRI grade; HE: IVD morphology improvement; immunohistochemistry: collagen II and aggrecan content increased | [68] |
| Honokiol | Injected intraperitoneally | 30 mg/kg/d | 4 | Decrease Pfirrmann MRI grade; HE and Alcian blue: IVD morphology improved; immunohistochemistry: MMP13 and ADAMATS-5 expression decreased | [74] |
| Intragastric administration | 40 mg/kg/d | 4 | Decrease Pfirrmann MRI grade; HE: IVD morphology improvement; immunofluorescence: upregulation of SIRT3 expression | [76] | |
| Salvianolic acid B | Intragastric administration | 20 mg/kg/d | 6 | Decrease Pfirrmann MRI grade; HE, safranin-O fast green, and Alcian blue: IVD shape improvement | [79] |
| Tea polyphenol | Local injection | 100 μM/week | 4 | Decrease Pfirrmann MRI grade; HE, safranin-O fast green, and Alcian blue: IVD shape improvement; immunohistochemistry: collagen II and aggrecan content increased | [82] |
| Icariin | Injected intraperitoneally | 30 mg/kg/d | 8 | Decrease the Pfirrmann MRI grade; increase the height of the IVD; immunohistochemistry: aggrecan content increased; TUNEL: decreased rate of positive cells | [93] |
| Naringin | Injected intraperitoneally | 80 mg/kg/d | 4 and 12 | Decrease Pfirrmann MRI grade; HE: IVD morphology improved | [101] |
| Genistein | Intragastric administration | 100 mg/kg/d | 4 | X-ray: increased intervertebral space height; HE: improved IVD morphology; Immunofluorescence: upregulated expression of Nrf2 | [107] |
| Local injection | 5 μg/mL, 10 μg/mL, 20 μg/mL/week | 2 and 4 | Decrease Pfirrmann MRI grade; HE: improve the structure of the intervertebral disc in a dose-dependent manner; immunohistochemistry: increase the expression of collagen II in a dose-dependent manner | [108] | |
| Wogonin | Local injection | 50 μM/week | 4 and 8 | Decrease Pfirrmann MRI grade; HE: IVD morphology improvement | [111] |
| Luteoloside | Injected intraperitoneally | 10 mg/kg/d | 4 and 8 | Decrease the Pfirrmann MRI grade; X-ray: increased intervertebral space height; HE and safranin-O fast green: IVD morphology improvement | [114] |
| Quercetin | Injected intraperitoneally | 100 mg/kg/d | 8 | X-ray: increased intervertebral space height; HE and safranin-O fast green: IVD morphology improvement; immunofluorescence: downregulation of caspase-3 expression, upregulation of SIRT1 expression | [117] |
| Berberine | Injected intraperitoneally | 150 mg/kg/d | 8 | Decrease Pfirrmann MRI grade; HE and safranin-O fast green: IVD morphology improvement; TUNEL: decreased rate of positive cells | [128] |
| Intragastric administration | 150 mg/kg/d | 4 | Decrease Pfirrmann MRI grade; HE: IVD morphology improvement; immunofluorescence: downregulation of caspase-3 expression | [129] | |
| Oxymatrine | Local injection | Oxymatrine 10 μM; Oxymatrine 10 μM + LIP100 μg/μL | 4 | X-ray radiology: oxymatrine-LIP can partially restore the height of the IVD | [132] |